Development dataset | Test dataset | ||
Age (year), mean (SD) | 49.1 (28.6) | 47.9 (15.4) | |
AL (mm), median (min, max) | 27.91 (26.50 to 36.84) | 30.05 (26.53 to 32.72) | |
SE (diopter), median (min, max) | −12.25 (−30.75 to −6.00) | −15.75 (−28.75 to −6.00) | |
No of women (%) | 538 (51.3%) | 54 (59.3%) | |
Training | Validation | ||
No of patients (%) | 838 (80%) | 210 (20%) | 91 (100%) |
No of images | 4338 | 1167 | 412 |
Retinoschisis | 1681 (38.8%) images | 497 (42.6%) images | 90 (43.6%) examinations |
Macular hole | 531 (12.2%) images | 180 (15.4%) images | 34 (16.5%) examinations |
Retinal detachment | 637 (14.7%) images | 202 (17.3%) images | 38 (18.4%) examinations |
PMCNV | 383 (8.8%) images | 87 (7.4%) images | 42 (20.3%) examinations |
Negative for all | 2190 (50.4%) images | 571 (48.8%) images | 79 (38.3%) examinations |
Total | 4338 images | 1167 images | 206 examinations |
PMCNV is for pathological myopic choroidal neovascularisation.
AL, axial length; PMCNV, pathological myopic choroidal neovascularisation.